State Street
PLYX icon

State Street’s Polaryx Therapeutics Inc PLYX Stock Holding History

State Street’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$141K Buy
68,004
+9,900
+17% +$21.6K ﹤0.01% 4000
2026
Q2 		$155K Hold
58,104
– – ﹤0.01% 3960
2026
Q1 		$439K Buy
+58,104
New +$375K ﹤0.01% 3693

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $87.3B AUM 22.01% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $225B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

State Street's PLYX Position: Q3 2026 in Review

State Street increased its Polaryx Therapeutics Inc (PLYX) stake by 17% in Q3 2026, buying an estimated $21.6K and bringing the position to 68,004 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #4000.

State Street first reported a position in PLYX in Q1 2026 and has held it in 3 quarters since. The position peaked at $439K in Q1 2026. 11 funds tracked by Wall St. Rank hold PLYX as of Q3 2026.

  • State Street held 68,004 shares of Polaryx Therapeutics Inc worth $141K as of Q3 2026.
  • State Street bought 9,900 Polaryx Therapeutics Inc shares in Q3 2026, an estimated $21.6K.
  • Polaryx Therapeutics Inc made up ﹤0.01% of State Street's portfolio in Q3 2026, its #4000 holding.
  • State Street first reported a position in Polaryx Therapeutics Inc in Q1 2026 and has held it in 3 quarters since.
  • State Street's Polaryx Therapeutics Inc position peaked at $439K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.